In mice with chronic kidney disease, the degree of aryl hydrocarbon receptor activation and uremic metabolite accumulation drives muscle mitochondrial dysfunction via PDK4 upregulation, which decreases mitochondrial pyruvate oxidation. Here, AHR is linked to chronic kidney disease.